EN DE
Watch Coreline Soft, Co., Ltd. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Coreline Soft, Co., Ltd. (384470) fair value: what the stock is really worth

As of Nov 16, 2026: fair value (intrinsic value) of Coreline Soft, Co., Ltd. stock KRW 1,652, price KRW 2,090, that is 21.0% below the price, quality 18 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare KR

CS Coreline Soft, Co., Ltd. logo Thin data Nov 16, 2026

Coreline Soft, Co., Ltd.

384470 · KQ

Expensive (fair value 21% below the price), weak company and falling price: meets none of the 3 rules.

Get notified free when this changes
Revenue last quarter +43% vs. a year ago. 
Moderate debt 
Fair value 1,652 KRW · Overvalued 
Quality 18/100 
Falling price (downtrend) 
Weak Growth (revenue 3y +1.5 %/yr in KRW) 
Negative free cash flow 
Trails peers (1/9) 
Narrow moat 8/100 · thin data
Thin data 
Estimate
Watch Coreline Soft, Co., Ltd. for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

37,048 KRW 1,997 KRW Fair Value 1,652 KRW Sep 2023 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.

How to read this chart

38‑month range 1,997 KRW – 37,048 KRW · fair‑value band 1,239 KRW – 2,065 KRW · the 2,090 KRW price screens above the 1,652 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.

Follow Coreline Soft, Co. in your weekly email

Every Wednesday you see whether Coreline Soft, Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Coreline Soft Co., Ltd. develops medical software to provide diagnosis and image solution for lung diseases.

Show moreShow less

It offers AVIEW Metric-Lung, a quantitative image biomarker software of COPD using chest CT images; AVIEW Modeler, a three-dimensional (3D) modeling software for 3D printing; and AVIEW Research, a software for medical research data management.

The company was founded in 2012 and is based in Seoul, South Korea.

Stock analysis

Coreline Soft, Co., Ltd. (384470) currently trades at 2,090 KRW, while our estimate is 1,652 KRW, 21% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: 1,239 KRW (bear) to 2,065 KRW (bull), the price of 2,090 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 18/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak: less than 2 % a year.

Coreline Soft, Co., Ltd. reported revenue of 4.3B KRW in FY2025 versus 2.2B KRW in FY2021, a compound +18.7%/yr. Reported net income was −14.5B KRW in FY2025.

Key figures

Market cap 37.5B KRW (≈ $28.0M) Micro · P/S ratio 7.25 · EPS (TTM) −773.90 KRW · Return on equity −73.9% · Return on assets (EBIT) −78.7% (5-year average) · Operating margin −149% · Revenue (TTM) 5.2B KRW · Revenue growth (YoY) +43.2%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 8 out of 100 (low confidence).

What moves the price

The share trades about 54% below its 52-week high and 5% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −9% fair-value upside, at −21%, 384470 screens richer than that median.

Fair Value

Bear 1,239 KRW Fair Value 1,652 KRW Bull 2,065 KRW
Price 2,090 KRW · Downside -21.0%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 18/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 4
How much profit the company makes from its sales and capital
Quality Growth 74
Are margins and returns getting better?
Cashflow 7
Do the profits arrive as real cash?
Financial strength 28
Debt, balance sheet and risk of trouble
Investment 0
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 5
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 2
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 8/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
+9.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.5%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−341.0% (2021) → −313.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

384470 screens overvalued: fair value 21% below the price. Compare with Thermo Fisher Scientific Inc →

Compare Coreline Soft, Co., Ltd. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 151 stocks

Beats the industry median on 1/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 18 · Bottom 25%
Fair Value upside −21.0% · Below median
Profitability
Return on assets −35.5% · Bottom 25%
Operating margin (12 months) −149.4% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 43.2% · Top 25%
Balance sheet
Debt / equity 0.60× · Highest 25%

Valuation Multiplesvs Diagnostics & Research median · lower = cheaper

P/B 2.06× · Pricier than median
P/S (12 months) 7.23× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)5 · sector 19
FUTURE (revenue growth)100 · sector 40
PAST (return on equity)0 · sector 9
HEALTH (low debt)70 · sector 95
DIVIDEND (yield)0 · sector 33

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Illumina, Inc ILMN $198.00 $227.71 +15% vs 384470
WuXi AppTec Co 603259 ¥144.41 ¥164.66 +14% vs 384470
IQVIA Holdings IQV $264.73 $291.63 +10% vs 384470
Thermo Fisher Scientific Inc TMO $691.33 $686.04 −1% vs 384470
Danaher Corporation DHR $229.91 $209.18 −9% vs 384470
IDEXX Laboratories, Inc IDXX $700.65 $496.48 −29% vs 384470
Lonza Group LONN CHF 670.20 CHF 259.80 −61% vs 384470
Mettler-Toledo International Inc MTD $1,727 $655.06 −62% vs 384470
Agilent Technologies, Inc A $172.92 $64.20 −63% vs 384470
Waters Corporation WAT $453.42 $91.26 −80% vs 384470

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Coreline Soft, Co., Ltd.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Coreline Soft, Co., Ltd. Fair Value". https://www.fairvalue-calculator.com/stock/384470

Frequently asked questions

Is Coreline Soft, Co., Ltd. (384470) overvalued or undervalued?
As of Nov 16, 2026, our estimate of fair value is 1,652 KRW versus a price of 2,090 KRW, about 21% lower (overvalued).
What is the fair value of 384470?
Our estimate for Coreline Soft, Co., Ltd. is 1,652 KRW (as of Nov 16, 2026), built from audited fundamentals. The current price: 2,090 KRW.
What is the quality score of 384470?
Coreline Soft, Co., Ltd. has a Quality Score of 18/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Coreline Soft, Co., Ltd. (384470)?
Our calculated price target is the estimate of 1,652 KRW (as of Nov 16, 2026). Cautious scenario 1,239 KRW, optimistic scenario 2,065 KRW. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Coreline Soft, Co., Ltd. stock forecast for 2026?
Our estimate puts fair value at 1,652 KRW, about 21% lower versus a price of 2,090 KRW (overvalued). Cautious scenario 1,239 KRW, optimistic scenario 2,065 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Coreline Soft, Co., Ltd. (384470)?
Coreline Soft, Co., Ltd. reported trailing-twelve-month revenue of about 5.2B KRW (latest available figure, as of Nov 16, 2026).
What is the intrinsic value of Coreline Soft, Co., Ltd. (384470)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Coreline Soft, Co., Ltd. it is 1,652 KRW per share (as of Nov 16, 2026), against a price of 2,090 KRW.
Is Coreline Soft, Co., Ltd. stock overvalued or undervalued in 2026?
As of Nov 16, 2026, 384470 trades above its calculated fair value: price 2,090 KRW, fair value 1,652 KRW, a gap of about −21% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 384470?
No. The price is what the market pays today (2,090 KRW); the fair value is what the company's own numbers justify (1,652 KRW). For Coreline Soft, Co., Ltd. the two are 438.30 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Coreline Soft, Co., Ltd. worth?
The market values Coreline Soft, Co., Ltd. at about 37.5B KRW (market capitalisation, as of Nov 16, 2026). Per share that is 2,090 KRW; our models calculate a fair value of 1,652 KRW per share.
What do the bullish and bearish scenarios say about 384470?
Our models span a range for Coreline Soft, Co., Ltd.: cautious scenario 1,239 KRW, base 1,652 KRW, optimistic 2,065 KRW per share (as of Nov 16, 2026, price 2,090 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Coreline Soft, Co., Ltd. (384470)?
Balance-sheet figures for Coreline Soft, Co., Ltd. (as of Nov 16, 2026): return on equity −73.9%, debt of 0.60 per unit of equity. They feed the Quality Score of 18/100, which measures business quality independently of the share price.
How far is 384470 from its 52-week high?
Coreline Soft, Co., Ltd. trades at 2,090 KRW, about 54% below its 52-week high of 4,495 KRW and 5% above the low of 1,997 KRW (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of 1,652 KRW is for.
Which stocks are comparable to Coreline Soft, Co., Ltd.?
From the same area (Healthcare) we also value Thermo Fisher Scientific Inc, Danaher Corporation, WuXi AppTec Co, Lonza Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Coreline Soft, Co., Ltd. stock attractive at the current price?
The data as of Nov 16, 2026: price 2,090 KRW, calculated fair value 1,652 KRW (−21%), Quality Score 18/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6% above its aggregate fair value. Coreline Soft, Co., Ltd. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Coreline Soft, Co., Ltd. (384470)?
The closing price on Nov 16, 2026 was 2,090 KRW. Our estimate is 1,652 KRW, about 21% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Coreline Soft, Co., Ltd. right now?
Weak quality (18/100) and above fair value at the same time, the margin of safety is missing on both counts. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Coreline Soft, Co., Ltd.

How large is the market capitalisation of Coreline Soft, Co., Ltd. (384470)?
The market capitalisation of Coreline Soft, Co., Ltd. is 37.5B KRW (≈ $28.0M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Coreline Soft, Co., Ltd. (384470)?
The price-to-sales ratio of Coreline Soft, Co., Ltd. is 7.25 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Coreline Soft, Co., Ltd. (384470)?
Earnings per share at Coreline Soft, Co., Ltd. are −773.90 KRW. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Coreline Soft, Co., Ltd. (384470)?
The return on equity (ROE) of Coreline Soft, Co., Ltd. is −73.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Coreline Soft, Co., Ltd. (384470)?
On an EBIT basis the return on assets of Coreline Soft, Co., Ltd. is −78.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Coreline Soft, Co., Ltd. (384470)?
The operating margin of Coreline Soft, Co., Ltd. is −149% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Coreline Soft, Co., Ltd. (384470)?
Revenue at Coreline Soft, Co., Ltd. is growing 43.2% versus a year earlier (3y avg +1.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Coreline Soft, Co., Ltd. (384470) generate?
The free cash flow of Coreline Soft, Co., Ltd. is −15.0B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Coreline Soft, Co., Ltd. (384470) carry?
The net debt of Coreline Soft, Co., Ltd. is 11.0B KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Coreline Soft, Co., Ltd. in the live analysis

One click puts Coreline Soft, Co., Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.